Gene Doping Detection From the Perspective of 3D Genome
Drug Testing and Analysis · 2025
DOI: 10.1002/dta.3850 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Xinyuan Ren und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Doping Control, Shanghai University of Sport, Shanghai, China. Hauptthemen laut MEDLINE: Doping in Sports, Genome, Human, Substance Abuse Detection. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 151 Literaturangaben. Gefördert von: Key Research and Development Plan of the Ministry of Science and Technology, Shanghai Jiao Tong University STAR, Shanghai Gaofeng and Gaoyuan Project for the University Academic Program Development.
Abstract (Originalsprache)
Since the early 20th century, the concept of doping was first introduced. To achieve better athletic performance, chemical substances were used. By the mid‐20th century, it became gradually recognized that the illegal use of doping substances can seriously endangered athletes' health and compromised the fairness of sports competitions. Over the past 30 years, the World Anti‐Doping Agency (WADA) has established corresponding rules and regulations to prohibit athletes from using doping substances or restrict the use of certain drugs, and isotope, chromatography, and mass spectrometry techniques were accredited to detect doping substances. With the development of gene editing technology, many genetic diseases have been effectively treated, but enabled by the same technology, doping has also the potential to pose a threat to sports in the form of gene doping. WADA has explicitly indicated gene doping in the Prohibited List as a prohibited method (M3) and approved qPCR detection. However, gene doping can easily evade detection, if the target genes' upstream regulatory elements are considered, the task became more challenging. Hi‐C experiment driven 3D genome technology, through perspectives such as topologically associating domain (TAD) and chromatin loop, provides a more comprehensive and in‐depth understanding of gene regulation and expression, thereby better preventing the potential use of 3D genome level gene doping. In this work, we will explore gene doping from a different perspective by analyzing recent studies on gene doping and explore related genes under 3D genome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Institute for Doping Control, Shanghai University of Sport, Shanghai, China.
- Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Shanghai Jiao Tong University, Shanghai, China.
- Faculty of Physical Education, Shanghai Jiao Tong University, Shanghai, China.
- Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
- Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Xianbin Su, Yi Shi
Förderung
- Key Research and Development Plan of the Ministry of Science and Technology
- Shanghai Jiao Tong University STAR
- Shanghai Gaofeng and Gaoyuan Project for the University Academic Program Development
Zitieren
APA
Ren, X., Shi, Y., Xiao, B., Su, X., Shi, H., He, G., Chen, P., Wu, D., & Shi, Y. (2025). Gene Doping Detection From the Perspective of 3D Genome. Drug Testing and Analysis. https://doi.org/10.1002/dta.3850
Vancouver
Ren X, Shi Y, Xiao B, Su X, Shi H, He G, et al. Gene Doping Detection From the Perspective of 3D Genome. Drug Testing and Analysis. 2025. doi:10.1002/dta.3850
BibTeX
@article{Ren2025,
author = {Ren, Xinyuan and Shi, Yue and Xiao, Bo and Su, Xianbin and Shi, Hui and He, Guang and Chen, Peijie and Wu, Die and Shi, Yi},
title = {Gene Doping Detection From the Perspective of 3D Genome},
journal = {Drug Testing and Analysis},
year = {2025},
doi = {10.1002/dta.3850}
}
EUVIMED